These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30149418)

  • 1. Statins and Colorectal Cancer - A Systematic Review.
    Dobrzycka M; Spychalski P; Łachiński AJ; Kobiela P; Jędrusik P; Kobiela J
    Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):255-262. PubMed ID: 30149418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of statins for individualized colorectal cancer chemoprevention.
    Jacobs RJ; Kodach LL; Hardwick JC
    Curr Drug Targets; 2011 Dec; 12(13):1903-8. PubMed ID: 21158709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the colorectum: hope for chemoprevention?
    Baron JA
    Cancer Prev Res (Phila); 2010 May; 3(5):573-5. PubMed ID: 20403999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and colorectal cancer.
    Lochhead P; Chan AT
    Clin Gastroenterol Hepatol; 2013 Feb; 11(2):109-18; quiz e13-4. PubMed ID: 22982096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer.
    Pikoulis E; Margonis GA; Angelou A; Zografos GC; Antoniou E
    Eur J Cancer Prev; 2016 Mar; 25(2):102-8. PubMed ID: 25768976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and the risk of colorectal adenoma: A meta-analysis.
    Jung YS; Park CH; Eun CS; Park DI; Han DS
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1823-1830. PubMed ID: 27043957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statins for the prevention of colorectal carcinoma: not yet recommended].
    Koornstra JJ; Kleibeuker JH
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2388-91. PubMed ID: 16277127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
    Jacobs EJ; Rodriguez C; Brady KA; Connell CJ; Thun MJ; Calle EE
    J Natl Cancer Inst; 2006 Jan; 98(1):69-72. PubMed ID: 16391373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
    Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
    EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and cancer prevention.
    Demierre MF; Higgins PD; Gruber SB; Hawk E; Lippman SM
    Nat Rev Cancer; 2005 Dec; 5(12):930-42. PubMed ID: 16341084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pleiotropic Effects of Statins in Endocrine Disorders.
    De La Cruz JA; Mihos CG; Horvath SA; Santana O
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):787-793. PubMed ID: 30924424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy in cardiovascular diseases other than atherosclerosis.
    Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
    Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and the risk of colorectal cancer.
    Poynter JN; Gruber SB; Higgins PD; Almog R; Bonner JD; Rennert HS; Low M; Greenson JK; Rennert G
    N Engl J Med; 2005 May; 352(21):2184-92. PubMed ID: 15917383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort.
    Lash TL; Riis AH; Ostenfeld EB; Erichsen R; Vyberg M; Ahern TP; Thorlacius-Ussing O
    Am J Epidemiol; 2017 Sep; 186(6):679-687. PubMed ID: 28338891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
    Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
    Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.